Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of digestive system, respiratory system, anti- infective, anti-virus and other fields in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.
Frequently asked questions
What sector does Hainan Huluwa Pharmaceutical Group Co Ltd (605199) operate in?
Hainan Huluwa Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Hainan Huluwa Pharmaceutical Group Co Ltd (605199) current stock price?
As of the latest data, Hainan Huluwa Pharmaceutical Group Co Ltd stock price is CN¥5.99, with a previous close of CN¥6.06. Hainan Huluwa Pharmaceutical Group Co Ltd lost -CN¥0.07 in the last trading session, representing a -1.16% loss.
What is Hainan Huluwa Pharmaceutical Group Co Ltd (605199) current market capitalization?
Hainan Huluwa Pharmaceutical Group Co Ltd market cap is approximately 2.40 billion.
What is Hainan Huluwa Pharmaceutical Group Co Ltd (605199) Earnings Per Share (EPS)?
The trailing EPS is -CN¥1.01.
Does Hainan Huluwa Pharmaceutical Group Co Ltd (605199) pay dividends?
No. Hainan Huluwa Pharmaceutical Group Co Ltd does not pay a dividend.
What is Hainan Huluwa Pharmaceutical Group Co Ltd (605199) beta (volatility) score?
Hainan Huluwa Pharmaceutical Group Co Ltd has a beta of 0.326, indicating lower volatility than the overall market.